AG200-SP

AG200-SP is an investigational combined hormonal contraceptive transdermal patch regimen developed by Agile Therapeutics as a follow‑on to its lead patch AG200-15. It is designed as a novel 28‑day contraceptive patch regimen that extends hormone delivery beyond the traditional 21‑day schedule, with the goal of optimizing the bleeding profile by providing shorter, lighter withdrawal bleeds and potentially improving contraceptive efficacy and user satisfaction. The regimen uses a lower‑dose combination of ethinyl estradiol and levonorgestrel delivered transdermally, leveraging the same active hormonal components as AG200‑15 but in a modified dosing schedule and possibly altered patch configuration to refine cycle control and tolerability.[1][5][13]